LIN28B, lin-28 homolog B, 389421

N. diseases: 126; N. variants: 24
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242379
Disease: Malignant neoplasm of lung
Malignant neoplasm of lung
0.060 Biomarker disease BEFREE MiR-563 plays a tumor suppressive role in lung cancer progression via targeting oncogenic LIN28B. 31766078 2020
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.060 Biomarker disease BEFREE MiR-563 plays a tumor suppressive role in lung cancer progression via targeting oncogenic LIN28B. 31766078 2020
CUI: C1306460
Disease: Primary malignant neoplasm of lung
Primary malignant neoplasm of lung
0.060 Biomarker disease BEFREE MiR-563 plays a tumor suppressive role in lung cancer progression via targeting oncogenic LIN28B. 31766078 2020
CUI: C0024121
Disease: Lung Neoplasms
Lung Neoplasms
0.010 AlteredExpression group BEFREE The level of miR-563 and LIN28B and their correlation were analyzed in 27 cases of lung tumor tissues by real-time PCR. 31766078 2020
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.080 Biomarker disease BEFREE Our data reveal that Lin28B may serve as a predictive biomarker and a treatment target to reverse HCC chemotherapy resistance in future clinical practice. 31762817 2019
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.040 Biomarker disease BEFREE LIN28B/IRS1 axis is targeted by miR-30a-5p and promotes tumor growth in colorectal cancer. 31713927 2019
Malignant neoplasm of colon and/or rectum
0.020 Biomarker disease BEFREE LIN28B/IRS1 axis is targeted by miR-30a-5p and promotes tumor growth in colorectal cancer. 31713927 2019
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.100 Biomarker phenotype BEFREE Knockdown of LIN28B in OS13 cells reduced tumorigenesis, decreased chemoresistance, and reversed oxidative phosphorylation function. 31705593 2020
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.100 AlteredExpression phenotype BEFREE KLK6 overexpression also induced the RNA-binding protein LIN28B and high-mobility group AT-hook 2 (HMGA2) transcription factor, two essential regulators of cell invasion and metastasis. 31692974 2019
CUI: C0007131
Disease: Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
0.060 AlteredExpression disease BEFREE Research has revealed that microRNA (miR)‑4500 is downregulated in non‑small cell lung cancer (NSCLC), and miR‑4500 suppresses tumor growth by targeting lin‑28 homolog B and NRAS proto‑oncogene, GTPase. 31638206 2019
CUI: C0011884
Disease: Diabetic Retinopathy
Diabetic Retinopathy
0.010 Biomarker disease BEFREE Further, in vivo experiments are needed for the application of miR-152/LIN28B axis in the treatment for diabetic retinopathy. 31609010 2020
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.900 AlteredExpression disease BEFREE The results also establish that LIN28B overexpression supports neuroblastoma onset and the metastatic potential of malignant cells through let-7a-dependent and let-7a-independent mechanisms. 31601998 2020
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.100 AlteredExpression disease BEFREE The results also establish that LIN28B overexpression supports neuroblastoma onset and the metastatic potential of malignant cells through let-7a-dependent and let-7a-independent mechanisms. 31601998 2020
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.100 AlteredExpression disease BEFREE The results also establish that LIN28B overexpression supports neuroblastoma onset and the metastatic potential of malignant cells through let-7a-dependent and let-7a-independent mechanisms. 31601998 2020
CUI: C0005890
Disease: Body Height
Body Height
0.100 GeneticVariation phenotype GWASCAT Characterizing rare and low-frequency height-associated variants in the Japanese population. 31562340 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.400 Biomarker group BEFREE Notably, downregulation of RPSAP52 impairs the balance between the oncogene LIN28B and the tumor suppressor let-7 family of miRNAs, inhibits cellular proliferation and migration in vitro and slows down tumor growth in vivo. 31484926 2019
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.010 Biomarker phenotype BEFREE Here, we show that LIN28A and LIN28B are significantly lower and lethal-7 (<i>let-7</i>) microRNAs (miRNAs) significantly higher in term human IUGR <i>vs.</i> normal placentas. 31415216 2019
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.100 Biomarker phenotype BEFREE These results suggested that exosomes derived from local cancer could promote the formation of distant metastases through transferring the exosomal protein Lin28B to the metastatic cancer cells. 31413760 2019
CUI: C2939419
Disease: Secondary Neoplasm
Secondary Neoplasm
0.010 Biomarker group BEFREE These results suggested that exosomes derived from local cancer could promote the formation of distant metastases through transferring the exosomal protein Lin28B to the metastatic cancer cells. 31413760 2019
CUI: C0005890
Disease: Body Height
Body Height
0.100 GeneticVariation phenotype GWASCAT Genetic analyses of diverse populations improves discovery for complex traits. 31217584 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.400 Biomarker group BEFREE Considering the similarities between cancer and trophoblast cells, we hypothesize that LIN28B also is necessary for the presence of AR in human trophoblast cells. 31215730 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker group BEFREE Considering the similarities between cancer and trophoblast cells, we hypothesize that LIN28B also is necessary for the presence of AR in human trophoblast cells. 31215730 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.400 AlteredExpression group BEFREE Analysis of LIN28B and HMGA2 expression levels in cohorts from The Cancer Genome Atlas sarcoma dataset revealed a strong inverse-relationship between elevated expression and overall survival (OS) in 260 patients (p = 0.005) and disease-free survival (DFS) in 231 patients (p = 0.02), suggesting LIN28B and HMGA2 are important regulators of sarcoma biology. 31147574 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 AlteredExpression group BEFREE Analysis of LIN28B and HMGA2 expression levels in cohorts from The Cancer Genome Atlas sarcoma dataset revealed a strong inverse-relationship between elevated expression and overall survival (OS) in 260 patients (p = 0.005) and disease-free survival (DFS) in 231 patients (p = 0.02), suggesting LIN28B and HMGA2 are important regulators of sarcoma biology. 31147574 2019
CUI: C1261473
Disease: Sarcoma
Sarcoma
0.020 Biomarker group BEFREE Our results highlight an important role for the LIN28B/LET-7 axis in human sarcoma pathogenesis and suggest that the therapeutic targeting of LIN28B may be relevant for patients with sarcoma. 31147574 2019